Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Surgical management of distant metastases.

David W Ollila1, Abigail S Caudle

  • 1Division of Surgical Oncology and Endocrine Surgery, University of North Carolina at Chapel Hill, School of Medicine, 3010 Old Clinic Building, Chapel Hill, NC 27599-7213, USA. david_ollila@med.unc.edu

Surgical Oncology Clinics of North America
|April 25, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ASO Visual Abstract: Implementing Paradigm-Shifting Clinical Trials: Real-World Outcomes of Neoadjuvant Versus Adjuvant Immune Checkpoint Inhibitors in Advanced Melanoma Patients.

Annals of surgical oncology·2026
Same author

Implementing Paradigm Shifting Clinical Trials: Real-World Outcomes of Neoadjuvant Versus Adjuvant Immune Checkpoint Inhibitors in Advanced Melanoma Patients.

Annals of surgical oncology·2026
Same author

Clipped Node Pathology as a Guide for Limited Axillary Surgery in Occult Breast Cancer.

Annals of surgery·2026
Same author

Breslow Thickness and Microsatellite Detection in Primary Cutaneous Melanoma: Implications for Oncologic Surgeons and Patients.

The American surgeon·2026
Same author

ASO Visual Abstract: Evaluation of Clinical Outcomes and Pattern of Recurrence in Patients With Cutaneous Melanoma and Sentinel Lymph Node Positivity Since the Publication of the MSLT-2 Trial.

Annals of surgical oncology·2026
Same author

Impact of Age on Use of Neoadjuvant Chemoimmunotherapy and Outcomes for Patients with Triple-Negative Breast Cancer.

Annals of surgical oncology·2026
Same journal

Small Incisions, Big Impact-Robotic Surgery Is Revolutionizing Cancer Care.

Surgical oncology clinics of North America·2026
Same journal

Minimally Invasive and Robotic Surgery for Cancer.

Surgical oncology clinics of North America·2026
Same journal

TeleSurgery: The Present and the Future for Minimally Invasive and Robotic Surgery.

Surgical oncology clinics of North America·2026
Same journal

Minimally Invasive and Robotic Surgery for Rectal Cancer.

Surgical oncology clinics of North America·2026
Same journal

Minimally Invasive/Robotic Surgery for Colon Cancer.

Surgical oncology clinics of North America·2026
Same journal

Minimally Invasive Surgery in Liver Transplantation.

Surgical oncology clinics of North America·2026
See all related articles

For stage IV melanoma patients, identifying surgically resectable metastatic disease through close monitoring is crucial. Complete surgical resection offers survival advantages over other treatments for metastatic melanoma.

Area of Science:

  • Oncology
  • Surgical Oncology
  • Melanoma Research

Background:

  • Metastasis location impacts prognosis in stage IV melanoma.
  • Current staging systems highlight the importance of metastatic site.
  • Early detection of metastatic melanoma is key for treatment options.

Purpose of the Study:

  • To review the principles of managing stage IV melanoma.
  • To evaluate the role of surgical resection in metastatic melanoma.
  • To compare surgical resection with systemic therapies for stage IV melanoma.

Main Methods:

  • Systematic review of principles for stage IV melanoma management.
  • Analysis of prognostic importance of metastasis location.
  • Evaluation of surgical resection outcomes versus systemic therapies.

Related Experiment Videos

Main Results:

  • Close patient monitoring can identify surgically resectable metastatic disease.
  • Complete surgical resection of metastases confers significant survival advantages.
  • Incomplete resection offers no survival benefit and increases risk; reserved for palliation.
  • Systemic adjuvant therapies currently lack the survival benefit of complete surgical resection.

Conclusions:

  • Complete metastectomy, when technically feasible, is the preferred treatment for stage IV melanoma.
  • Surgical resection should be prioritized over evolving systemic therapies until they demonstrate superior survival.
  • Aggressive surgical management should be balanced with patient selection and technical feasibility.